- Home
- LLY
as 07-26-2024 4:00pm EST
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.
| Founded: | 1876 | Country: | United States |
| Employees: | N/A | City: | INDIANAPOLIS |
| Market Cap: | 834.9B | IPO Year: | N/A |
| Target Price: | $871.68 | AVG Volume (30 days): | 3.3M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 20 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 6.79 | EPS Growth: | 7.95 |
| 52 Week Low/High: | $446.89 - $966.10 | Next Earning Date: | 08-08-2024 |
| Revenue: | $35,932,100,000 | Revenue Growth: | 29.76% |
| Revenue Growth (this year): | 27.44% | Revenue Growth (next year): | 23.36% |
Stock Insider Trading Activity of Eli Lilly and Company (LLY)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $944.90 | 3,500 | $3,307,146.50 | 96,943,810 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $936.90 | 25,067 | $23,485,146.97 | 97,128,743 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $938.03 | 14,916 | $13,991,625.65 | 97,113,827 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $939.11 | 28,486 | $26,751,487.46 | 97,085,341 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $939.95 | 92,882 | $87,304,621.66 | 96,992,459 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $940.87 | 29,147 | $27,423,479.60 | 96,963,312 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $941.96 | 2,198 | $2,070,432.48 | 96,961,114 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $943.09 | 4,519 | $4,261,841.79 | 96,956,595 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 10 '24 | Sell | $944.06 | 9,285 | $8,765,615.67 | 96,947,310 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 5 '24 | Sell | $915.14 | 50,540 | $46,251,377.76 | 97,249,232 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 5 '24 | Sell | $916.25 | 1,829 | $1,675,815.76 | 97,247,403 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 3 '24 | Sell | $915.14 | 8,048 | $7,365,078.91 | 97,300,572 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 3 '24 | Sell | $916.21 | 400 | $366,485.20 | 97,300,172 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 3 '24 | Sell | $917.73 | 400 | $367,090.40 | 97,299,772 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 1 '24 | Sell | $915.17 | 53,949 | $49,372,560.28 | 97,313,420 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jul 1 '24 | Sell | $916.30 | 4,800 | $4,398,216.00 | 97,308,620 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 28 '24 | Sell | $915.02 | 1,441 | $1,318,545.26 | 97,367,369 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 24 '24 | Sell | $902.30 | 16,029 | $14,462,966.70 | 97,558,110 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 24 '24 | Sell | $903.42 | 1,200 | $1,084,101.60 | 97,556,910 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 20 '24 | Sell | $902.25 | 6,552 | $5,911,561.66 | 97,577,258 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 20 '24 | Sell | $903.50 | 2,919 | $2,637,322.34 | 97,574,339 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 20 '24 | Sell | $904.25 | 200 | $180,849.00 | 97,574,139 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 17 '24 | Sell | $882.45 | 36,716 | $32,400,144.35 | 97,742,072 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 17 '24 | Sell | $883.43 | 22,282 | $19,684,676.39 | 97,719,790 | SEC Form 4 |
| LILLY ENDOWMENT INC | LLY | 10% Owner | Jun 17 '24 | Sell | $884.56 | 11,820 | $10,455,499.20 | 97,707,970 | SEC Form 4 |
Latest Eli Lilly and Company News
LLY Breaking Stock News: Dive into LLY Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
6 hours ago
June PCE inflation print, auto earnings: Morning Brief
Zacks
8 hours ago
Is Eli Lilly's Stock in a Bubble?
Yahoo Finance Video
9 hours ago
Eli Lilly loses $120B in value over Viking's GLP-1 progress
Zacks
11 hours ago
Should You Invest in Novo Nordisk (NVO) Ahead of Q2 Earnings?
Motley Fool
12 hours ago
Prediction: This Is What Eli Lilly Stock Will Do Next
Investopedia
12 hours ago
Watch These Eli Lilly Stock Price Levels as Weight-Loss Drug Competition Rises
Motley Fool
a day ago
Why Weight Loss Drug Developer Stocks Tumbled on Thursday
Bloomberg
a day ago
Lilly Loses $120 Billion in Value as Rival Obesity Drugs Impress
Compare LLY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LLY Eli Lilly and Company - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.